WIA
SGMO

World Investment Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

World Investment Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-42,611
Closed -$28.7K – 1546
2025
Q3 		$28.7K Buy
42,611
+20,000
+88% +$10.8K ﹤0.01% 1226
2025
Q2 		$12.2K Hold
22,611
– – ﹤0.01% 1127
2025
Q1 		$14.8K Hold
22,611
– – ﹤0.01% 1046
2024
Q4 		$23.1K Hold
22,611
– – ﹤0.01% 996
2024
Q3 		$19.6K Hold
22,611
– – ﹤0.01% 901
2024
Q2 		$8.1K Buy
+22,611
New +$12.2K ﹤0.01% 620

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

World Investment Advisors's SGMO Position: Q4 2025 in Review

World Investment Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2025, closing a stake of 42,611 shares — an estimated $28.7K sold.

World Investment Advisors first reported a position in SGMO in Q2 2024 and held it in 6 quarters. The position peaked at $28.7K in Q3 2025. 105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.

  • World Investment Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2025 after selling out during the quarter.
  • World Investment Advisors sold 42,611 SANGAMO THERAPEUTICS INC shares in Q4 2025, an estimated $28.7K.
  • World Investment Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2024 and held it in 6 quarters.
  • World Investment Advisors's SANGAMO THERAPEUTICS INC position peaked at $28.7K in Q3 2025.
  • 105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.

Based on World Investment Advisors's 13F filing for Q4 2025, filed 4 Feb 2026.